Mentions
Extended reach
Total likes
Video views
AI synopsis
Many discussions reflect on the study's suggestion that PDE5 inhibitors like Viagra may reduce Alzheimer's risk, with remarks such as 'The biggest question anyone has about Viagra is obviously can it reduce the risk of Alzheimer's,' indicating a mix of humor and genuine inquiry. Phrases like 'some good news for a change' and 'intriguing' enhance the tone of optimism surrounding the findings, contributing to the overall positive sentiment of the discourse.
The majority of discussions express a favorable view toward the findings of the study, indicating general support for its conclusions.
There is a strong curiosity about the connection between erectile dysfunction medications and Alzheimer’s disease risk, with many participants discussing the implications of the findings.
While some comments are straightforward, several participants delve into the mechanisms and nuances of PDE5 inhibitors, revealing a moderate level of engagement.
Many discussions highlight the potential significance of these findings in healthcare experiences, suggesting that users see these results as having notable implications.
מחקר על 270,000 גברים הראה שלמי שהשתמש בוויאגרה/סיאליס היה סיכוי נמוך יותר לפתח אלצהיימר. בגלל אופי המחקר (תצפיתי) יש שאלות פתוחות: האם זה בגלל התרופה? או אולי מה שמגן זה דווקא הסקס? או אולי מי שזוכר איך לעשות סקס פשוט זוכר יותר טוב? https://t.co/Gco00Bi1OE
Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease | Neurology https://t.co/JJ6Sbb7MrS
אולי יש תקווה... מחקר חדש מצא קשר מסקרן בין נטילת תרופות להפרעות זיקפה כמו לבין סיכון נמוך יותר לפתח מחלת אלצהיימר. במחקר על 269,725 גברים, נמצא שאלו שלקחו את התרופות להפרעות זיקפה, כמו ויאגרה וסיאליס, היו בסיכון נמוך ב-18% לפתח דמנציה. https://t.co/GA7d19Wfpa https://t.co/jbopQRnAwe
In this study, phosphodiesterase type 5 inhibitor initiation in men with erectile dysfunction was associated with a lower risk of #Alzheimer disease, particularly in those most frequently issued prescriptions. Learn more: https://t.co/7olR3yUwPX #NeuroTwitter https://t.co/I6jclG4IAT
興味深いことに、この認知症予防効果はバイアグラの投与量が多い人でより顕著に見られたようだ。 Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease | Neurology https://t.co/IzaM7wh7sQ
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease
This video summarizes the latest scientific news, focusing on a study investigating the relationship between phosphodiesterase type 5 inhibitors (PDE5Is) and Alzheimer’s disease risk in men. Discover the findings and…
This video explores the health benefits of olive oil rich in polyphenols like Hydroxytyrosol, which may enhance cognitive function and reduce cardiovascular risks. It also examines the negative effects of fast food on…
Learn about the safety of Viagra (sildenafil) and its recent association with a lower risk of Alzheimer's disease among men with erectile dysfunction. This video covers essential guidelines and recent research findings…
Viagra and Cialis are being studied for their surprising effects on the brain. Research suggests that the improved blood flow from these medications may help reduce the risk of Alzheimer's disease. Learn more about…
ED治療薬を飲んでる男性はアルツハイマー型認知症になりにくいかも知れない Neurology https://t.co/qDOVXbIcJ7 https://t.co/V0l6HtQj2Z
Open Access UCL Research: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease discovery.ucl.ac.uk/id/eprint/10...
RT @timothycbates: contra-banger: Treatment for erectile dysfunction is associated with reduced Alzheimer's disease :-) The mechanism is CN…
RT @timothycbates: contra-banger: Treatment for erectile dysfunction is associated with reduced Alzheimer's disease :-) The mechanism is CN…
RT @timothycbates: contra-banger: Treatment for erectile dysfunction is associated with reduced Alzheimer's disease :-) The mechanism is CN…
RT @timothycbates: contra-banger: Treatment for erectile dysfunction is associated with reduced Alzheimer's disease :-) The mechanism is CN…
contra-banger: Treatment for erectile dysfunction is associated with reduced Alzheimer's disease :-) The mechanism is CNS capillary dilation by e.g., Viagra or Cialis, increasing blood flow, which is halved in Dementia. https://t.co/HAOBVAdFai
Fonte: https://t.co/FfAkpO2yMU
Another reason to take the little blue pill? Men with ED who take PDE5 drugs like Viagra may have less risk of developing Alzheimer’s, says study. https://t.co/zzI3KH06lU
バイアグラがアルツハイマー効く可能性。 https://t.co/cGhqRkuqLz
RT @StevePhillipsMD: Erectile dysfunction drugs reduce risks for Alzheimer's, but how?
RT @StevePhillipsMD: Erectile dysfunction drugs reduce risks for Alzheimer's, but how?
Erectile dysfunction drugs reduce risks for Alzheimer's, but how?
EDの治療に用いられるPDE5阻害薬がアルツハイマー病のリスクを下げる可能性。使用頻度が関連？フォロー機関が3年未満の人を除外すると有意差はみられなかった。Neurology. 2024;102:e209131. PMID:38324745. https://t.co/Jxdouzfm0x
RT @agingdoc1: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease
RT @bostancicenk: Ereksiyon hapları Alzheimer hastalığından koruyor, üstelik daha çok kullananlarda daha da az saptanıyor (doz-cevap etkisi…
Ereksiyon hapları Alzheimer hastalığından koruyor, üstelik daha çok kullananlarda daha da az saptanıyor (doz-cevap etkisi). 269,725 erkek üzerinde yapılan sağlık veri tabanı çalışması https://t.co/7zJIIcIiu4
https://t.co/wo2AzSy57Z 「シルデナフィル(※バイアグラのこと)は勃起維持に必要不可欠なcGMPを分解するPDE-5を阻害する作用があるのでするので勃起補助効果がある」 ホスホジエステラーゼ5阻害薬（PDE5i）がアルツハイマーを予防するんちゃう？っていうのはこれやな https://t.co/hcISc2aX66
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of #Alzheimer Disease @GreenJournal #CGFPsicología https://t.co/cSecCqAim3
PDE5I initiation in men with erectile dysfunction is associated with a lower risk of Alzheimer's disease https://t.co/zJbnP7FH0z
{Fighting Stigma} Study Finds Association Between Erectile Dysfunction Treatments and Reduced Risk of ...: Adesuyan M, Jani YH, Alsugeir D, et al. Phosphodiesterase type 5 inhibitors in men with erectile dysfunction and the risk of alzheimer disease: a ... https://t.co/a1F4EodaqZ
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease. PDE5I initiation in men with erectile dysfunction was associated with a lower risk of Alzheimer disease. https://t.co/WyhkLl100t
@Bchiesin También https://t.co/AlYK4WKbcs
RCTやれよということだが、バイアグラなんかの勃起薬(PDE5is)と、アルツハイマー型認知症リスクの低下が関係あるかもという研究 シアリスは前立腺肥大症の治療薬でもあるし、面白いね ただ、PDE5isには聴力低下の報告もあるんだなあ なんでそんな必死なのって？ いや別に… https://t.co/MBBBIoQtkv
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease https://t.co/kCI7Z7fx6d https://t.co/feFMqh5PRM
Erectile dysfunction drugs linked to reduced Alzheimer's risk https://t.co/V9Y14QN1hP The authors of the new Neurology paper found that men prescribed #erectiledysfunction drugs (#Viagra) were 18% less likely to develop #AlzheimersDisease disease years later. Intriguing. Some
Erectile dysfunction drugs linked to reduced Alzheimer's risk https://t.co/V9Y14QN1hP The authors of the new Neurology paper found that men prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s disease years later. Intriguing. Some
The biggest question anyone has about Viagra is obviously can it reduce risk of Alzheimer's. And, wouldn't you know it, it maybe kinda can. #Alzheimer, #dementia https://t.co/tmcOLzGRGw
RT @GreenJournal: In this study, phosphodiesterase type 5 inhibitor initiation in men with erectile dysfunction was associated with a lower…
RT @GreenJournal: In this study, phosphodiesterase type 5 inhibitor initiation in men with erectile dysfunction was associated with a lower…
RT @GreenJournal: In this study, phosphodiesterase type 5 inhibitor initiation in men with erectile dysfunction was associated with a lower…
RT @GreenJournal: In this study, phosphodiesterase type 5 inhibitor initiation in men with erectile dysfunction was associated with a lower…
RT @GreenJournal: In this study, phosphodiesterase type 5 inhibitor initiation in men with erectile dysfunction was associated with a lower…
In this study, phosphodiesterase type 5 inhibitor initiation in men with erectile dysfunction was associated with a lower risk of #Alzheimer disease, particularly in those most frequently issued prescriptions. Learn more: https://t.co/7olR3yUwPX #NeuroTwitter https://t.co/I6jclG4IAT
Could ED medication hold the key to lowering Alzheimer's risk?
Could ED medication hold the key to lowering Alzheimer's risk?
Could your ED medication hold the key to lowering Alzheimer's risk?
"PDE5I initiation in men with ED was associated with a lower risk of AD, particularly in those most frequently issued prescriptions" https://t.co/FoZVCDBEg7
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease | Neurology https://t.co/Y6Sw8RoLeT
RT @erlesen: While findings are striking, the observational study cannot determine whether Viagra and similar pills protect against Alzheim…
https://t.co/b52H7j2JYM
@NatureAging Nice validation by Neurology Journal in an independent drug cohort design: https://t.co/NvP9q2aej0
https://t.co/1u5rlR1tBI
La Tierra pudo ser plana al principio https://t.co/CzMtJui0L5 a través de @YouTube
La Tierra pudo ser plana al principio https://t.co/RNT8IUfxX9 a través de @YouTube
文献 https://t.co/JYuF4VgKqb
More evidence that #Viagra (& related drugs) reduces the risk of #Alzheimers disease. "PDE5I initiation in men with ED was associated with a lower risk of AD, particularly in those most frequently issued prescriptions..." https://t.co/oGw67S1n35.
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease. PDE5I initiation in men with ED was associated with a lower risk of AD. https://t.co/Wv3CjHnrog
RT @rincondesisifo: (Neurology) Seguridad y eficacia de los iPD5 en personas con riesgo de sufrir la enfermedad de Alzheimer https://t.co/L…
Some good news for a change: New research suggests men prescribed erectile dysfunction drugs may also be less likely to develop Alzheimer’s disease years later. @elonmu Men With Erectile Dysfunction and the Risk of Alzheimer Disease | Neurology https://t.co/zaK7F1okX6
RT @IdoWolf1: מחקר על 270,000 גברים הראה שלמי שהשתמש בוויאגרה/סיאליס היה סיכוי נמוך יותר לפתח אלצהיימר. בגלל אופי המחקר (תצפיתי) יש שאלות…
אולי יש תקווה... מחקר חדש מצא קשר מסקרן בין נטילת תרופות להפרעות זיקפה כמו לבין סיכון נמוך יותר לפתח מחלת אלצהיימר. במחקר על 269,725 גברים, נמצא שאלו שלקחו את התרופות להפרעות זיקפה, כמו ויאגרה וסיאליס, היו בסיכון נמוך ב-18% לפתח דמנציה. https://t.co/GA7d19Wfpa https://t.co/jbopQRnAwe
RT @IdoWolf1: מחקר על 270,000 גברים הראה שלמי שהשתמש בוויאגרה/סיאליס היה סיכוי נמוך יותר לפתח אלצהיימר. בגלל אופי המחקר (תצפיתי) יש שאלות…
מחקר על 270,000 גברים הראה שלמי שהשתמש בוויאגרה/סיאליס היה סיכוי נמוך יותר לפתח אלצהיימר. בגלל אופי המחקר (תצפיתי) יש שאלות פתוחות: האם זה בגלל התרופה? או אולי מה שמגן זה דווקא הסקס? או אולי מי שזוכר איך לעשות סקס פשוט זוכר יותר טוב? https://t.co/Gco00Bi1OE
RT @ichiipsy: 興味深いことに、この認知症予防効果はバイアグラの投与量が多い人でより顕著に見られたようだ。 Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the R…
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease | Neurology https://t.co/FIbQQZqlLu
@jijicom こういうの原著論文もつけてほしいよね https://t.co/zoWbOQDRXR
Que vivan los segundos usos ! https://t.co/qF0lUoLkxp
RT @ichiipsy: 興味深いことに、この認知症予防効果はバイアグラの投与量が多い人でより顕著に見られたようだ。 Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the R…
RT @ichiipsy: 興味深いことに、この認知症予防効果はバイアグラの投与量が多い人でより顕著に見られたようだ。 Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the R…
興味深いことに、この認知症予防効果はバイアグラの投与量が多い人でより顕著に見られたようだ。 Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease | Neurology https://t.co/IzaM7wh7sQ
RT @rincondesisifo: (Neurology) Seguridad y eficacia de los iPD5 en personas con riesgo de sufrir la enfermedad de Alzheimer https://t.co/L…
RT @psychopharmacol: Cohort Study: Phosphodiesterase type 5 inhibitors initiation in men with ED was associated with a lower risk of AD, pa…
Cohort Study: Phosphodiesterase type 5 inhibitors initiation in men with ED was associated with a lower risk of AD, particularly in those most frequently issued prescriptions (aHR=0.82; 0.72–0.93) https://t.co/2zvHA0i3GD https://t.co/b0uTrJqEY3
Looks like PDE5i is good for both heads
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @DanaAlSugeir: Our study published today and led by Matthew Adesuyan found Phosphodiesterase Type 5 Inhibitors were associated with a re…
(Neurology) Seguridad y eficacia de los iPD5 en personas con riesgo de sufrir la enfermedad de Alzheimer https://t.co/L8EnJqRXxx Est Observ https://t.co/5AByCWbi3c
RT @CTrivalle: Les médicaments contre les troubles de l'érection seraient associés à un risque réduit de maladie d'Alzheimer Phosphodiest…
Les médicaments contre les troubles de l'érection seraient associés à un risque réduit de maladie d'Alzheimer Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease | Neurology https://t.co/Ph4QHuTGrI
Via @GreenJournal: Phosphodiesterase type 5 inhibitors were associated with a lower risk of Alzheimer’s disease in men with erectile dysfunction, especially those who frequently filled prescriptions for the drugs: https://t.co/hlNvADSbF5 #NeuroTwitter #dementia https://t.co/zpPuyBCmEo
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
最強のクスリやん
【Neurology Feb 7 2024】 Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease https://t.co/uRhFpr49wl
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @DanaAlSugeir: Our study published today and led by Matthew Adesuyan found Phosphodiesterase Type 5 Inhibitors were associated with a re…
Our study published today and led by Matthew Adesuyan found Phosphodiesterase Type 5 Inhibitors were associated with a reduced risk of Alzheimer’s disease in men with Erectile Dysfunction. #UCL @RdppU @LiWeiUCL Link
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
Here's the data on Viagra and Alzheimer's, which has been reported widely today It's a cohort study of 269,725 men in the UK The effect is quite small and limited to certain subgroups. Still, interesting! https://t.co/O0ab201NFM https://t.co/nfWJljPDMA https://t.co/vh9cBsdEn3
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
Today I have to shout my friend and fellow pharmacist, Matthew Adesuyan conducting groundbreaking research on PDE5Is role in reducing dementia risk https://t.co/JGVDN4I04e featured in most UK media outlets. Here’s to more pharmacy professionals doing groundbreaking research
“ The findings of this large population-based study suggest that the use of PDE5I may be associated with a reduced risk of incident AD.” #Alzheimerdisease #sildenafil https://t.co/CuCZMaD8Ew
Phosphodiesterase type 5 inhibitor prescription associated with 18% reduction in Alzheimer's disease risk in UK electronic health record study of 270k men. Effect larger in those with more prescriptions. Something to think long and hard about
Popping a Viagra a day might keep the…. Alzheimer’s away
RT @agingdoc1: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease
https://t.co/end1O2UYxa Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease A Cohort Study Here's a new one https://t.co/u692bZkvFi
RT @agingdoc1: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @DanielJDrucker: Will the little blue pill keep you smarter over time? #AlzheimersDisease https://t.co/Ughv0rXF1L
Will the little blue pill keep you smarter over time? #AlzheimersDisease https://t.co/Ughv0rXF1L
Was not expecting to look at a study this morning (large, but retrospective) supporting Viagra to be decrease Alzhiemer’s risk, and dont think we should just put it in the water, but here it is: https://t.co/MSkFhCX2VS
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ScienceofPD: PDE5I initiation in men with erectile dysfunction was associated with a lower risk of #Alzheimers, particularly in those m…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @pash22: @metapredict @MadhavThambiset @ucl @guardian @iansample @LiWeiUCL @ProfRobHoward @seb_walsh @LonSchneiderMD @EWidera @nvillain_…
RT @ScienceofPD: PDE5I initiation in men with erectile dysfunction was associated with a lower risk of #Alzheimers, particularly in those m…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @metodologica_cl:
@metapredict @MadhavThambiset @ucl @guardian @iansample @LiWeiUCL @ProfRobHoward @seb_walsh @LonSchneiderMD @EWidera @nvillain_alz @ProfRobHoward & @LiWeiUCL et al have just published another article "Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study" https://t.co/aDdkOrJZqP
RT @metodologica_cl:
RT @metodologica_cl:
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @CMORE2improve: Viagra should be researched as a potential treatment for dementia -Congratulations to CMORE clinical academic pharmacist…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @CMORE2improve: Viagra should be researched as a potential treatment for dementia -Congratulations to CMORE clinical academic pharmacist…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
RT @ProfRobHoward: Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the…
Open access version of our paper out today: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease | Neurology https://t.co/JJ6Sbb7MrS
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease The findings of this large population-based study suggest that the use of PDE5I may be associated with a reduced risk of incident AD.
Viagra should be researched as a potential treatment for dementia -Congratulations to CMORE clinical academic pharmacist Matthew - paper published and reported in BBC news! @uclh https://t.co/Se3FwU3WhF https://t.co/58XgaZddVu
RT @agingdoc1: Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease